As of 2025-10-29, the Relative Valuation of Kezar Life Sciences Inc (KZR) is (131.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.25 USD, the upside of Kezar Life Sciences Inc based on Relative Valuation is -2203.2%.
The range of the Relative Valuation is (105.84) - (146.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 17.2x | 15.6x |
| Forward P/E multiples | 12.3x - 18.7x | 15.4x |
| Fair Price | (105.84) - (146.21) | (131.45) |
| Upside | -1793.4% - -2439.3% | -2203.2% |
| Date | P/E |
| 2025-10-28 | -0.73 |
| 2025-10-27 | -0.73 |
| 2025-10-24 | -0.73 |
| 2025-10-23 | -0.73 |
| 2025-10-22 | -0.73 |
| 2025-10-21 | -0.73 |
| 2025-10-20 | -0.74 |
| 2025-10-17 | -0.75 |
| 2025-10-16 | -0.49 |
| 2025-10-15 | -0.51 |
| 2025-10-14 | -0.51 |
| 2025-10-13 | -0.51 |
| 2025-10-10 | -0.50 |
| 2025-10-09 | -0.52 |
| 2025-10-08 | -0.49 |
| 2025-10-07 | -0.46 |
| 2025-10-06 | -0.46 |
| 2025-10-03 | -0.46 |
| 2025-10-02 | -0.46 |
| 2025-10-01 | -0.47 |
| 2025-09-30 | -0.46 |
| 2025-09-29 | -0.42 |
| 2025-09-26 | -0.43 |
| 2025-09-25 | -0.44 |
| 2025-09-24 | -0.45 |
| 2025-09-23 | -0.46 |
| 2025-09-22 | -0.45 |
| 2025-09-19 | -0.44 |
| 2025-09-18 | -0.44 |
| 2025-09-17 | -0.44 |
| 2025-09-16 | -0.44 |
| 2025-09-15 | -0.46 |
| 2025-09-12 | -0.47 |
| 2025-09-11 | -0.47 |
| 2025-09-10 | -0.47 |
| 2025-09-09 | -0.47 |
| 2025-09-08 | -0.47 |
| 2025-09-05 | -0.48 |
| 2025-09-04 | -0.45 |
| 2025-09-03 | -0.46 |
| 2025-09-02 | -0.45 |
| 2025-08-29 | -0.47 |
| 2025-08-28 | -0.47 |
| 2025-08-27 | -0.47 |
| 2025-08-26 | -0.47 |
| 2025-08-25 | -0.47 |
| 2025-08-22 | -0.48 |
| 2025-08-21 | -0.47 |
| 2025-08-20 | -0.46 |
| 2025-08-19 | -0.46 |